Radiopharm Theranostics Limited (AU:RAD) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Radiopharm Theranostics Limited has announced the application for quotation of a significant number of securities on the ASX, with an issue date of September 13, 2024. The application includes 93,750,000 ordinary fully paid shares and 46,875,000 options expiring in August 2026. This move indicates a potential expansion and investment opportunity for stakeholders in the pharmaceutical sector.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.